Abstract:OBJECTIVE:To explore the synergistic anti-tumor effect of radiotherapy and horseradish peroxidase/prodrug indole-3-acetic acid (HRP/IAA) gene therapy system using chimeric hTERT promoter responsive to ionizing radiation.METHODS:The synthetic hTERT promoters containing four tandem-repeat copies of radio-inducible CArG elements, and the chimeric promoter containing cytomegalovirus (CMV) early promoter were both constructed. The activities of the chimeric promoters in cancer cell lines (HeLa, A549, and MHCC97) and normal cell line (MRC-5) were detected using luciferase reporter gene expression analysis after a (60)Co γ-irradiation treatment at a series of doses(a single dose of 0 to 10 Gy). The anti-tumor effect of combining irradiation with HRP/IAA gene-directed enzyme prodrug therapy system controlled by the chimeric promoter was tested by colony formation assay, cell counting and apoptosis analysis.RESULTS:The chimeric promoters were ineffective in normal human cells, even after irradiation, but the expression of luciferase gene in tumor cells was significantly higher. The activity of the chimeric promoter in MRC-5 cells was 22.3%, 12.9% and 13.6% of that in HeLa, A549 and MHCC97 cells, respectively. After irradiation, the ratios were 11.7%, 8.7% and 8.8%, respectively. Furthermore, the chimeric promoters could successfully induce the expression of luciferase gene following different doses of radiation, with maximal inducible activity seen after 6 Gy irradiation. The chimeric promoter containing four tandem-repeat copies of radio-inducible CArG elements and CMV early promoter showed the highest activity with 6 Gy irradiation. The relative luciferase activities in HeLa, A549 and MHCC97 cells were 1.7 ± 0.2, 2.3 ± 0.2 and 2.3 ± 0.1, respectively. The chimeric promoter mediated suicide gene therapy system could increase radio-sensitivity in different cancer cells. Compared with the control system, it plus irradiation showed stronger cell proliferation inhibition, 67.3% vs. 26.1% in HeLa, 69.0% vs. 28.3% in A549, 64.6% vs. 20.8% in MHCC97 cells, and also higher apoptosis-inducing effect, 39.6% vs. 14.2% in HeLa, 33.0% vs. 12.4% in A549, and 33.2% vs. 14.2% in MHCC97 cells.CONCLUSIONS:Chimeric promoter containing hTERT promoter, CArG elements and CMV promoter preserve the tumor-specificity in telomerase-positive tumor cells, and irradiation-responsive to low dose of radiation. The suicide gene therapy using this promoter plus radiotherapy show a strong anti-tumor effect in vitro. It is expected to have a good potential for future application in gene radiotherapy.

[Anti-Tumor Effect of Suicide Gene Therapy Using Chimeric Promoter Plus Radiotherapy on Cancer Cell Lines].

Novel, Chimeric, Cancer-Specific, and Radiation-Inducible Gene Promoters for Suicide Gene Therapy of Cancer.

Anti-tumor Effect of Adenovirus-Mediated Suicide Gene Therapy under Control of Tumor-Specific and Radio-Inducible Chimeric Promoter in Combination with Γ-Ray Irradiation in Vivo

Radiobiology Effects of Radiation-Induced Horseradish Peroxidase/indole-3-acetic Suicide Gene Expression in Lung Cancer Cells

Radiation Enhances Suicide Gene Therapy in Radioresistant Laryngeal Squamous Cell Carcinoma Via Activation of A Tumor-Specific Promoter

Co-expression of Interleukin 12 Enhances Antitumor Effects of a Novel Chimeric Promoter-Mediated Suicide Gene Therapy in an Immunocompetent Mouse Model.

Study of cancer-specific chimeric promoters induced by irradiation

Enhanced Suicide Gene Therapy Using A Tumor-Specific Promoter in Combination with Cisplatin

[Htert Promoter Enhances the Radiosensitivity to Gene-Radiation Therapy of Human Laryngeal Carcinoma Transplanted in Nude Mice].

Radio-activation of Htert Promoter in Larynx Squamous Carcinoma Cells: an 'Indirected-Activator' Strategy in Radio-Gene-therapy.

Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.

4:10 PM Abstract No. 50 Intratumoral Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene Therapy of Orthotopic Lung Cancer Through the Augmentation of Apoptosis and Heat Shock Protein (HSP70) Expression Pathway

Progress of Hypoxia/radiation Dual-sensitive Promoter Controlling Suicide Gene Expression in Radiotherapy

Combined Treatment of Cholangiocarcinoma with Interventional Radiofrequency Hyperthermia and Heat Shock Protein Promoter-Mediated HSV-TK Gene Therapy.

Gene Therapy with Tumor-Specific Promoter Mediated Suicide Gene Plus IL-12 Gene Enhanced Tumor Inhibition and Prolonged Host Survival in a Murine Model of Lewis Lung Carcinoma

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Co-expression of Suicide gene Promotes the Apoptosis of HepG2 Cells

A Novel Synthetic Htert-Mini-cmv Chimera Promoter-Driven Tumor-Selective and High-Efficiency Expression of Transgene for Systemic Cancer Gene Therapy

The Progress of Tumor Gene-Radiotherapy Induced by Egr-1 Promoter

Development of Chimeric Gene Regulators for Cancer-specific Gene Therapy with both Transcriptional and Translational Targeting

In Vitro And In Vivo Tissue Specific Cytotoxicity Of Gastric Cancer Cells Resulting From Cd:Uprt/5-Fc Gene Therapy System Driven By Htert Promoter